Business · 25 February 2026

Novo Nordisk Ozempic cost drops to $675

Danish drugmaker Novo Nordisk announced plans to lower the United States list price of its diabetes drug Ozempic. The monthly cost for Ozempic will decrease to $675, which is about a third less than its current $1,027 price. These price reductions will begin on 1 January 2027 and will apply to all patients, regardless of insurance. Novo Nordisk aims to improve affordability and access for Americans.

By BriefTea Editorial · 25 February 2026 at 17:36

Reported by Reuters · How we write briefs

Get the app

More briefs

BusinessLondon Stock Exchange Group sued for £131m in fraud lawsuit BusinessApple to see UK crackdown on iPhone contactless payment fees BusinessRyanair boss warns of biggest ever European flight price hike BusinessThames Water creditors name Labour peer John Hutton as chair for proposed rescue BusinessMillions of Revolut and Lloyds customers hit by major outage BusinessElizabeth Holmes Documentary Takes $15m in Biggest Opening in 20 Years More business stories → Browse all stories →